Market Tracker

12/19 6:05pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

40.06
Data as of Dec 19
 -0.29 / -0.72%
Today’s Change
27.51
Today|||52-Week Range
40.58
+37.19%
Year-to-Date

Today’s Trading

Previous close40.35
Today’s open40.24
Day’s range38.23 - 40.58
Volume1,532,488
Average volume (3 months)757,904
Market cap$1.7B
Dividend yield--
Data as of 3:59pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-89.84%
Earnings growth (this year)+19.86%
Earnings growth (next 5 years)+45.00%
Revenue growth (last year)+10.01%
P/E ratio71.5
Price/Sales3.49
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
CBPOChina Biologic Produ...+1.30+1.97%
CMRXChimerix Inc+2.24+5.80%
HZNPHorizon Pharma PLC+0.35+2.71%
THRXTheravance Inc-0.00-0.03%
Data as of 4:00pm ET, 12/19/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$0.08
Annual revenue (last year)$336.4M
Annual profit (last year)$16.4M
Net profit margin4.89%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief-
Business Operations
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts